Marktgröße und Marktanteil von Medikamenten und Diagnostika auf Basis des menschlichen Mikrobioms bis 2025 – 2031
Human Microbiome Based Drugs and Diagnostics Market Report Analysis
Human Microbiome Based Drugs and Diagnostics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Second Genome Inc
- Enterome Bioscience
- Yakult
- DuPont
- Vedanta BioSciences
- Metabiomics Corporation
- ViThera Pharmaceuticals
- MicroBiome Therapeutics LLC
- Merck
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation
By Produkt
- Lebensmittel
- Probiotika
- Präbiotika
- medizinische Lebensmittel
- Diagnosegeräte
- Medikamente
- andere probiotische Nahrungsergänzungsmittel
By Anwendung
- Therapeutika
- Diagnostik
By Krankheit
- akuter Durchfall
- Fettleibigkeit
- Diabetes
- Autoimmunerkrankungen
- Krebs
- psychische Störungen
- andere Krankheiten
By Forschungsausgaben, Produkttyp
- Instrumente
- Verbrauchsmaterialien
Get Free Sample For